Literature DB >> 18579078

Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.

King-Ho Cheung1, Diana Shineman, Marioly Müller, César Cárdenas, Lijuan Mei, Jun Yang, Taisuke Tomita, Takeshi Iwatsubo, Virginia M-Y Lee, J Kevin Foskett.   

Abstract

Mutations in presenilins (PS) are the major cause of familial Alzheimer's disease (FAD) and have been associated with calcium (Ca2+) signaling abnormalities. Here, we demonstrate that FAD mutant PS1 (M146L)and PS2 (N141I) interact with the inositol 1,4,5-trisphosphate receptor (InsP3R) Ca2+ release channel and exert profound stimulatory effects on its gating activity in response to saturating and suboptimal levels of InsP3. These interactions result in exaggerated cellular Ca2+ signaling in response to agonist stimulation as well as enhanced low-level Ca2+signaling in unstimulated cells. Parallel studies in InsP3R-expressing and -deficient cells revealed that enhanced Ca2+ release from the endoplasmic reticulum as a result of the specific interaction of PS1-M146L with the InsP3R stimulates amyloid beta processing,an important feature of AD pathology. These observations provide molecular insights into the "Ca2+ dysregulation" hypothesis of AD pathogenesis and suggest novel targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579078      PMCID: PMC2495086          DOI: 10.1016/j.neuron.2008.04.015

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  67 in total

Review 1.  Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.

Authors:  Frank M LaFerla
Journal:  Nat Rev Neurosci       Date:  2002-11       Impact factor: 34.870

2.  Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4,5-trisphosphate-mediated calcium signals.

Authors:  M A Leissring; I Parker; F M LaFerla
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

Review 3.  Role of calcium ions in regulation of mammalian intramitochondrial metabolism.

Authors:  J G McCormack; A P Halestrap; R M Denton
Journal:  Physiol Rev       Date:  1990-04       Impact factor: 37.312

4.  APP processing and synaptic function.

Authors:  Flavio Kamenetz; Taisuke Tomita; Helen Hsieh; Guy Seabrook; David Borchelt; Takeshi Iwatsubo; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

5.  Reconstitution of gamma-secretase activity.

Authors:  Dieter Edbauer; Edith Winkler; Joerg T Regula; Brigitte Pesold; Harald Steiner; Christian Haass
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

6.  Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.

Authors:  E Ito; K Oka; R Etcheberrigaray; T J Nelson; D L McPhie; B Tofel-Grehl; G E Gibson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity.

Authors:  Sébastien S Hébert; Lutgarde Serneels; Tim Dejaegere; Katrien Horré; Michal Dabrowski; Veerle Baert; Wim Annaert; Dieter Hartmann; Bart De Strooper
Journal:  Neurobiol Dis       Date:  2004-11       Impact factor: 5.996

8.  Activity-dependent expression of inositol 1,4,5-trisphosphate receptor type 1 in hippocampal neurons.

Authors:  Weihua Cai; Chihiro Hisatsune; Kyoko Nakamura; Takeshi Nakamura; Takafumi Inoue; Katsuhiko Mikoshiba
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

Review 9.  Pathways towards and away from Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  Nature       Date:  2004-08-05       Impact factor: 49.962

10.  The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores.

Authors:  Giancarlo Zatti; Roberta Ghidoni; Laura Barbiero; Giuliano Binetti; Tullio Pozzan; Cristina Fasolato; Paola Pizzo
Journal:  Neurobiol Dis       Date:  2004-03       Impact factor: 5.996

View more
  215 in total

1.  Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation.

Authors:  Gary E Gibson; Huan-Lian Chen; Hui Xu; Linghua Qiu; Zuoshang Xu; Travis T Denton; Qingli Shi
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

Review 2.  Intracellular organelles in the saga of Ca2+ homeostasis: different molecules for different purposes?

Authors:  Enrico Zampese; Paola Pizzo
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

Review 3.  Calcium and mitochondrial reactive oxygen species generation: how to read the facts.

Authors:  Vera Adam-Vizi; Anatoly A Starkov
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

5.  Role of presenilins in neuronal calcium homeostasis.

Authors:  Hua Zhang; Suya Sun; An Herreman; Bart De Strooper; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

6.  The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma.

Authors:  Kazunori Shibao; Michael J Fiedler; Jun Nagata; Noritaka Minagawa; Keiji Hirata; Yoshifumi Nakayama; Yasuko Iwakiri; Michael H Nathanson; Koji Yamaguchi
Journal:  Cell Calcium       Date:  2010-11-13       Impact factor: 6.817

Review 7.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 8.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

9.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

10.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.